Naomi Kresge

Senior Reporter

Latest

Big Pharma Companies in Spain

Lilly Obesity Pill Shows No Added Heart Risk in Trial

April 16, 2026

April 16, 2026

Lilly Obesity Pill Shows No Added Heart Risk in Trial

Big Pharma Companies in Spain

April 16, 2026

April 16, 2026

Novo Nordisk Has Hired 2,000 This Year to Reshape Workforce

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark.

April 14, 2026

April 14, 2026

Novo Taps OpenAI to Speed Development of New Obesity Drugs

Novo Nordisk

April 7, 2026

April 7, 2026

Gilead to Buy Cancer Biotech Tubulis in $5 Billion Deal

Gilead Sciences Headquarters Ahead Of Earnings Figures

April 7, 2026

April 7, 2026

Novo Undercuts Lilly With High-Dose Wegovy at $399 a Month

Novo To Sell Weight-Loss Drug Wegovy Directly To Patients

April 1, 2026

April 1, 2026

Novo Digs In to Protect Its No. 1 Spot in Obesity Pill Market

Wegovy pills

March 26, 2026

March 26, 2026

Novo Says Priority Is Obesity Despite Investor Calls to Expand

Inside Novo Nordisk A/S "Factory Of The Future"

March 26, 2026

March 26, 2026

Novo Chairman Faces Testy Investors Over Lack of Progress

Novo Nordisk Chief Executive Officer Lars Soerensen Interview

March 20, 2026

March 20, 2026

Roche Pursues Muscle Study for Obesity After Halting Other Work

Headquarters of Swiss Pharma Giant Roche Holding AG

March 19, 2026

March 19, 2026

Novo’s High-Dose Wegovy Gets US Approval in Needed Boost

Wegovy Effect: A Weight Loss Wonder Drug's Impact on Denmark's Economy

March 19, 2026

March 19, 2026

Obesity Drug Tests Upended by Placebo Patients Leaving Early

Wegovy Weight Loss Pill Is Now Available In US

March 18, 2026

March 18, 2026

Study Shows Ozempic Is Linked to Lower Risk of Worsening Mental Health Issues

Inside Pharmacies As Trump Threatens Pharmaceutical Tariffs

March 10, 2026

March 10, 2026

FDA Warns Novo Over Unreported Potential Ozempic Side Effects, Deaths

Novo Nordisk A/S Scouts Deals to Gain New Medicines and Technology

March 10, 2026

March 10, 2026

BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm

Ugur Sahin and Özlem Türeci

March 9, 2026

March 9, 2026

Novo Drops Hims & Hers Lawsuit and Will Sell Wegovy on Site

Hims’ Super Bowl Ad Hit For ‘Misleading’ Weight-Loss Claims

March 9, 2026

March 9, 2026

Hims & Hers Surges on Novo Obesity Deal That Ends Public Feud

Hims’ Super Bowl Ad Hit For ‘Misleading’ Weight-Loss Claims

March 6, 2026

March 6, 2026

Generic Ozempic Could Cost Less Than $3 a Month, Study Shows

Novo Nordisk A/S Scouts Deals to Gain New Medicines and Technology

March 5, 2026

March 5, 2026

Zealand Plunge Pulls Roche Lower After Obesity Shot Disappoints

Roche Holding

March 2, 2026

March 2, 2026

Novo Invests $507 Million on Wegovy Pill Plant in Ireland

Wegovy Weight Loss Pill Is Now Available In US

February 26, 2026

February 26, 2026

Live Q&A: Can Novo Win Back Investors in Fierce Obesity Race?

Bloomberg journalists answer questions about Novo and the brutal weight-loss drug race on Friday, Feb. 27 at 8 a.m. ET

Live Novo HP